Rocky’s Weekly Stock Picks

This is an extra-short week. Markets will close at 1:00 PM on Monday, and remain closed through Tuesday to open again on Wednesday morning.

Leveraged ETFs aren’t a bad way to go. Despite the supposed risks involved, it seems like leveraged ETFs based on the S&P return an average of 25% each year, versus the regular S&P 500 of about 7%.

You can also short inverse leveraged ETFs, or buy a small quantity as a hedge. Your window of opportunity to sell at a huge profit will be very small if buying and holding as a hedge, and very few people would ever recommend doing so. BUT, since you can queue up a GTC order….it might just be worth putting a few hundred into a 3x Bear, just saying.

  1. ACVF - $33.85/share, American Conservative Values Fund. AMERICA! F*** YEAH! This is a no-brainer for the 4th of July, and for just having a reliable place to find capital appreciation.

    There’s also some kind of pithy dividend that we basically ignore, but it’s still nice to see each quarter.

  2. PINS - $27.36/share, options trade weekly. We think this is in a good place to short in the near-term. Short the shares, with a GTC buy order at $25 or $24.

    We’re not normally fans of shorting, but we are fans of LEAPs or covered calls, or even cash-secured puts on PINS. We just really like Pinterest.


  3. LOAN - $5.05/share, this REIT pays monthly to the tune of about 8.9%. Plus, what a great name!

  4. HAS - $64.77/share, ex-div 7/31, quarterly return of about 4.25%. Options trade monthly.

    There was a fund we were looking at recently that included Hasbro in its holdings. We lost our notes, but we started buying into HAS at $100/share, and maintain that anything below that mark is a discount. (We also plan to never sell. We’ll take the shares to our graves.)

    ….oh, you can’t do that? Guess we’ll just have to live forever, then.

  5. LIFE - $2.16/share. Options trade monthly. Speaking of living forever…this looks like trash. Apparently HC Wainright & Co. has a $35/share price target. Their main drug is tRNA-based treatment of system sclerosis ….

    Uhh…. uhm…. we don’t feel super good about this one. We’ll sell a couple long-term puts at $2.50. That’s about it.

    Maybe just one. This could also be a good YOLO if we hadn’t already thrown a few darts this year.

Previous
Previous

Rocky’s Weekly Stock Picks

Next
Next

Rocky’s Weekly Stock Picks